An experience of treatment of pneumomycosis with Medoflucon
Abstract
The article shows a scheme and treatment results for 88 adults with Candida bronchitis and pneumonia. Medoflucon (fluconazole) was included in a complex therapy as an etiotropic drug. As a result 66.7% of the Candida pneumonic patients and 74.7% of the Candida bronchitis ones recovered; 33.3% of the Candida pneumonic patients and 22.8% of the Candida bronchitis ones were improved.
About the Authors
G. V. Voyinova
Центр глубоких микозов; ГКБ № 81
Russian Federation
Russian Federation
S. A. Burova
Центр глубоких микозов; ГКБ № 81
Russian Federation
Russian Federation
References
1. Бурова С.А., Меркулова Е.А., Егорова Т.П. Микробиологическая характеристика некоторых глубоких микозов. Вестник дерматологии 1994; 2: 6-7.
2. Бурова С.А. Проблемы грибковых заболеваний человека. Рос. жури. кож. и вен. бол. 1998; 1: 39-41.
3. Knoke М., Schulz K., Bernharelt H. Dynamics oí Candida populations in the last four years. In 3rd meeting oí the European confideration of medical mycology. Lisbon 1996. 22-25.
4. Pfaller M.A. Epidemiological typing for mycoses. Clin. Infect. Dis. 1992; 1: 14 (suppl. 1): S4-S10.
5. Wenzel R.P. Epidemiology of nosocomial candida infections. Infect. Dis. Clin. Pract. 1994; (supp. 2): 556-559.
Review
For citations:
Voyinova G.V., Burova S.A. An experience of treatment of pneumomycosis with Medoflucon. PULMONOLOGIYA. 2001;(1):35-36. (In Russ.)
Views:
226
Email this article 